Cite
HARVARD Citation
Cunningham, D. et al. (n.d.). Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial. Lancet oncology. 18 (3), pp. 357-370. [Online].